Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in Taiwan with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Not applicable Country / region: Taiwan Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20092
20122
20141
20162
20173
20181
20192
20201
20211
20233
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status5
Not yet recruiting2
Withdrawn1
Recruiting1
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital7
Kaohsiung Medical University Chung-Ho Memorial Hospital4
National Cheng-Kung University Hospital4
Chang Gung Memorial Hospital2
Chiayi Christian Hospital1
Dalin Tzu Chi General Hospital1
Far Eastern Memorial Hospital1
National Atomic Research Institute, Taiwan1
National Health Research Institutes, Taiwan1
National Taipei University of Nursing and Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular26
Liver Neoplasms8
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Adenoma, Islet Cell1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Diabetes Mellitus, Type 21
Gastrointestinal Stromal Tumors1
Glioma1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.